Kinestase en es it fr

Kinestase Brand names, Kinestase Analogs

Kinestase Brand Names Mixture

  • No information avaliable

Kinestase Chemical_Formula


Kinestase RX_link

Kinestase fda sheet

Kinestase msds (material safety sheet)

Kinestase MSDS

Kinestase Synthesis Reference

No information avaliable

Kinestase Molecular Weight

465.945 g/mol

Kinestase Melting Point

110 oC

Kinestase H2O Solubility

2.71 mg/L

Kinestase State


Kinestase LogP


Kinestase Dosage Forms

Suspension; Tablet

Kinestase Indication

For the symptomatic treatment of adult patients with nocturnal heartburn due to gastroesophageal reflux disease.

Kinestase Pharmacology

Cisapride is a parasympathomimetic which acts as a serotonin 5-HT4 agonist. Stimulation of the serotonin receptors increases acetylcholine release in the enteric nervous system. Cisapride stimulates motility of the upper gastrointestinal tract without stimulating gastric, biliary, or pancreatic secretions. Cisapride increases the tone and amplitude of gastric (especially antral) contractions, relaxes the pyloric sphincter and the duodenal bulb, and increases peristalsis of the duodenum and jejunum resulting in accelerated gastric emptying and intestinal transit. It increases the resting tone of the lower esophageal sphincter. It has little, if any, effect on the motility of the colon or gallbladder. Cisapride does not induce muscarinic or nicotinic receptor stimulation, nor does it inhibit acetylcholinesterase activity.

Kinestase Absorption

Cisapride is rapidly absorbed after oral administration, with an absolute bioavailability of 35-40%.

Kinestase side effects and Toxicity

No information avaliable

Kinestase Patient Information

No information avaliable

Kinestase Organisms Affected

Humans and other mammals